PhoenixBio Co., Ltd. (TYO:6190)
497.00
+3.00 (0.61%)
Feb 17, 2026, 10:53 AM JST
PhoenixBio Company Description
PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally.
The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services.
Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications.
The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
PhoenixBio Co., Ltd.
| Country | Japan |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 69 |
| CEO | Takashi Shimada |
Contact Details
Address: 3-4-1 Kagamiyama Higashihiroshima, 739-0046 Japan | |
| Phone | 81 8 2431 0016 |
| Website | phoenixbio.co.jp |
Stock Details
| Ticker Symbol | 6190 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3803010002 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Takashi Shimada | Chief Executive Officer |